The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Special report
First-in-human experience with the Medtronic CoreValve Evolut R
EuroIntervention 2014;9:1260-1263 published online ahead of print December 2013. DOI: 10.4244/EIJV9I11A215
Nicolo Piazza1*, MD, PhD; Giuseppe Martucci1, MD; Kevin Lachapelle2, MD; Benoit de Varennes2, MD; Luc Bilodeau1, MD; Jean Buithieu1, MD; Darren Mylotte1, MD
1. The Department of Interventional Cardiology, McGill University Health Centre, Montreal, Quebec, Canada; 2. Cardiovascular Surgery, McGill University Health Centre, Montreal, Quebec, Canada
The CoreValve Evolut R with EnVeo R delivery catheter is a novel transcatheter heart valve (THV) system with enhanced features that have the potential to improve the safety of transcatheter aortic valve implantation (TAVI). T